Eli Lilly and Company · 3 days ago
Advisor – RNA-LNP Process Development – BR&D
US, Boston MA
Full-time
Onsite
New Grad, Entry, Mid, Senior Level
$166K/yr - $244K/yr
0+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana, focused on discovering and bringing life-changing medicines to those in need. They are seeking a highly motivated engineer to drive innovation efforts in the process engineering of genetic medicine programs, particularly RNA-lipid nanoparticles and other parenteral drug products.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Build process capabilities for lab scale, early phase clinical scale, and scale up technologies for RNA-LNPs and other parenteral drug products
Support the development of portfolio assets (particularly RNA-LNPs), including assessing and mitigating process risks during scale-up through an understanding of in-process and final product critical quality attributes. Anticipate and manage increased workload during scale-up and GMP readiness phases
Work with project management and other technical leaders to execute complex tech transfer challenges across sites, including both internal and external manufacturing organizations. Help oversee supply chain readiness and ensure integration of novel excipients into regulatory filing packages
Implement processes to deliver drug product material for clinical trials and support generating data required for regulatory filings, including addressing CMC regulatory questions
Ensure consistency in technical deliverables and documentation across transfers
Partner with analytical colleagues and aid in the transfer and installation of analytical methods to assess developability of portfolio molecules, including familiarity with acquisition and analysis of chromatography methods (e.g., SEC, HPLC, UHPLC methods)
Cross-Functional Collaboration: Represent the product research & development organization on project teams. Partner with genetic medicines discovery, synthetic chemistry, toxicology, ADME, analytical, and device to support drug delivery, formulation, or process efforts
External Engagement: Establish and leverage strategic relationships with academic and industry partners to accelerate and access emerging innovation
Innovation: Drive a strong innovation agenda for the team leading to publications, presentations and industry wide influence. Leverage these innovations to advance the Lilly portfolio
Qualification
Required
Ph.D. in Chemical Engineering, Biomedical Engineering, Chemistry, Pharmaceutical Sciences, or a related field
0-5 years of prior experience in nanoparticle formulations, oligonucleotide and/or gene delivery development programs, parenteral formulation, or process development
Experience with process development of RNA-lipid nanoparticle and/or oligonucleotide formulations
Familiarity with engineering fundamentals towards designing and optimizing manufacturing processes, or drug delivery platforms including RNAs and LNPs
Preferred
Hands-on experience working with process equipment from lab to pilot scales
Previous experience with regulatory submissions of RNA-based therapies
Self-directed and highly motivated individual who wants to learn new techniques while continually pursuing research and publication goals
Excellent communicator (oral and written) with presentation experience, along with a strong publication record
Proficient in data analysis and reporting
Benefits
Company bonus
Eligibility to participate in a company-sponsored 401(k)
Pension
Vacation benefits
Eligibility for medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
The Motley Fool
2026-01-19
Pharmaceutical Technology
2026-01-19
2026-01-18
Company data provided by crunchbase